Infections in Patients with Advanced-stage Epidermal Growth Factor Receptor-mutant Lung Cancer - a Post-hoc Analysis of a Randomised Trial

Clin Oncol (R Coll Radiol). 2023 Dec;35(12):811-812. doi: 10.1016/j.clon.2023.09.016. Epub 2023 Sep 29.

Authors

H Sahu¹, V M Patil², N Menon¹, A K Singh¹, S Biswas³, A Janu⁴, N Chakraborty³, K Prabhash¹, V Noronha¹

Affiliations

¹ Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
² Department of Medical Oncology, Hinduja Hospital, Mumbai, Maharashtra, India.
³ Department of Microbiology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
⁴ Department of Radiology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.

PMID: 37838606
DOI: 10.1016/j.clon.2023.09.016

No abstract available

Publication types

Randomized Controlled Trial
Letter

MeSH terms

Carcinoma, Non-Small-Cell Lung*
ErbB Receptors / genetics
Humans
Lung Neoplasms* / genetics
Mutation
Protein Kinase Inhibitors

Substances

ErbB Receptors
Protein Kinase Inhibitors